logo

GRANULES vs KREBSBIO: Stock Comparison

GRANULES INDIA vs KREBS BIOCHEMICALS & INDUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a higher dividend yield, faster revenue growth and a higher ROCE, while KREBS BIOCHEMICALS & IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 7; KREBSBIO leads 2 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESKREBSBIO

Valuation lens

What price are you paying?

Market CapContext only
₹22,358 Cr
₹125 Cr
P/E RatioKREBSBIO has the lower reading
30.39x
0x ✓
P/B RatioKREBSBIO has the lower reading
3.99x
0x ✓
EPSGRANULES has the higher reading
₹7.26 ✓
₹-1.15
Book ValueContext only
₹205.21
—
Dividend YieldGRANULES has the higher reading
0.22% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹22,358 Cr vs ₹125 Cr
P/E Ratio
KREBSBIO has a lower P/E
0x vs 30.39x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 3.99x
EPS
GRANULES has higher earnings per share
₹7.26 vs ₹-1.15
Dividend Yield
GRANULES has a higher dividend yield
0.22% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 11.6%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
ROCE
GRANULES has a higher ROCE
9.07% vs -15.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESKREBSBIO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESKREBSBIO
Live Price₹817₹57.48
Day Change1.16%2.53%
Volume5.12 L3,570
52-Week High₹923.65₹76.85
52-Week Low₹529.85₹38.33
Distance from 52W High-11.55%-25.2%

Valuation

MetricGRANULESKREBSBIO
Market Cap₹22,358 Cr₹125 Cr
P/E Ratio30.39x0x
P/B Ratio3.99x0x
EPS₹7.26₹-1.15
Book Value₹205.21—
Dividend Yield0.22%0%

Growth

MetricGRANULESKREBSBIO
Revenue Growth (TTM YoY)22.8%11.6%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricGRANULESKREBSBIO
ROE9.11%—
ROCE9.07%-15.89%
Net Margin11.15%-71.35%
Operating Margin17.19%-41.49%
Debt to Equity0.17x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGRANULESKREBSBIO
Promoter Holding37.08%▼ 0.59 pp72.74%
FII Holding20.25%▲ 2.75 pp0.5%
DII Holding15.33%▼ 0.78 pp0%
Public Holding27.04%▼ 1.34 pp26.76%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and KREBS BIOCHEMICALS & IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.